TipRanks on MSN

Gyre Therapeutics announces alignment with China’s CDE on hydronidone

Gyre Therapeutics (GYRE) announced that its majority-owned subsidiary in China, Gyre Pharmaceuticals Co., Ltd., completed a Pre-New Drug ...